Ignite Creation Date:
2024-05-06 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03593005
Status:
COMPLETED
Last Update Posted:
2020-01-07
First Post:
2018-07-09
Brief Title:
Acute Exposure to High Altitude on Symptoms
Sponsor:
University of Zurich
Organization:
University of Zurich
Study Overview
Official Title:
Acute Exposure to Hypoxia in Precapillary Pulmonary Hypertension Physiological and Clinical Effects at Rest and During Exercise
Status:
COMPLETED
Status Verified Date:
2020-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Randomized crossover Trial in patients with Pulmonary Hypertension PAH CTEPH to assess the acute response to High Altitude 2500m above sea level in altitude related symptoms
Detailed Description:
Low altitude baseline measurements will be performed in Zurich 460m asl including Echocardiography Right heart catheterization 6MWT pulmonary function test clinical assessment and blood gas Analysis
Randomly assigned to the order of testing the participants will be tested at Low Altitude Zurich 470m and High Altitude 2500m
Regularly during the exposure of approximately 5 hours the participants will be asked to complete altitude related symptom questionnaires
Randomly assigned to the order of testing the participants will be tested at Low Altitude Zurich 470m and High Altitude 2500m
Regularly during the exposure of approximately 5 hours the participants will be asked to complete altitude related symptom questionnaires
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None